Manulife (Manufacturers Life Insurance)
HTGM

Manulife (Manufacturers Life Insurance)’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio HTGM Stock Details HTGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-9
Closed -$4K – 4385
2017
Q2 		$4K Buy
9
+1
+13% +$758 ﹤0.01% 4010
2017
Q1 		$10K Hold
8
– – ﹤0.01% 3656
2016
Q4 		$3K Hold
8
– – ﹤0.01% 4066
2016
Q3 		$3K Hold
8
– – ﹤0.01% 4022
2016
Q2 		$4K Hold
8
– – ﹤0.01% 3887
2016
Q1 		$5K Buy
+8
New +$4.47K ﹤0.01% 3805
2015
Q4 		– Hold
0
– – – 4091
2015
Q3 		– Hold
0
– – – 3973
2015
Q2 		– Hold
0
– – – 3949

Other funds holding HTGM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s HTGM Position: Q3 2017 in Review

Manulife (Manufacturers Life Insurance) sold out of HTG Molecular Diagnostics, Inc. Common Stock (HTGM) in Q3 2017, closing a stake of 9 shares — an estimated $4K sold.

Manulife (Manufacturers Life Insurance) first reported a position in HTGM in Q1 2016 and held it in 6 quarters. The position peaked at $10K in Q1 2017. 21 funds tracked by Wall St. Rank hold HTGM as of Q3 2017.

  • Manulife (Manufacturers Life Insurance) reported no remaining HTG Molecular Diagnostics, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 9 HTG Molecular Diagnostics, Inc. Common Stock shares in Q3 2017, an estimated $4K.
  • Manulife (Manufacturers Life Insurance) first reported a position in HTG Molecular Diagnostics, Inc. Common Stock in Q1 2016 and held it in 6 quarters.
  • Manulife (Manufacturers Life Insurance)'s HTG Molecular Diagnostics, Inc. Common Stock position peaked at $10K in Q1 2017.
  • 21 funds tracked by Wall St. Rank held HTG Molecular Diagnostics, Inc. Common Stock as of Q3 2017.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2017, filed 14 Nov 2017.